Catalyst Pharmaceuticals (CPRX) Change in Cash (2010 - 2026)
Catalyst Pharmaceuticals posted quarterly Change in Cash of $46.7 million for Q1 2026, down 26.01% year-on-year from $63.1 million in Q1 2025, and up 142.17% on a QoQ basis from $19.3 million in Q4 2025.
Catalyst Pharmaceuticals (CPRX) has 17 years of Change in Cash data on file, last reported at $46.7 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash fell 26.01% year-over-year to $46.7 million; the trailing twelve-month figure through Mar 2026 stood at $175.2 million (down 35.17% YoY), and the FY2025 full-year result was $191.6 million, down 49.56% from the prior year.
- Change in Cash for Q1 2026 stood at $46.7 million, up from $19.3 million in the prior quarter.
- Across five years, Change in Cash topped out at $172.8 million in Q1 2024 and bottomed at -$150.1 million in Q1 2023.
- The 5-year median for Change in Cash is $42.3 million (2022), against an average of $34.4 million.
- The widest annual swing landed in 2023, when Change in Cash sank 2267.58%; it then surged 351.38% in 2024.
- A 5-year view of Change in Cash shows it stood at $42.3 million in 2022, then plunged by 60.63% to $16.7 million in 2023, then soared by 351.38% to $75.2 million in 2024, then sank by 74.37% to $19.3 million in 2025, then soared by 142.17% to $46.7 million in 2026.
- The last three Change in Cash figures came in at $46.7 million (Q1 2026), $19.3 million (Q4 2025), and $37.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | 46.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.69 Mn |
| Dec 31, 2025 | 19.28 Mn |
| Sep 30, 2025 | 37.09 Mn |
| Jun 30, 2025 | 72.14 Mn |
| Mar 31, 2025 | 63.10 Mn |
| Dec 31, 2024 | 75.22 Mn |
| Sep 30, 2024 | 66.64 Mn |
| Jun 30, 2024 | 65.28 Mn |
| Mar 31, 2024 | 172.78 Mn |
| Dec 31, 2023 | 16.67 Mn |
| Sep 30, 2023 | -57.82 Mn |
| Jun 30, 2023 | 30.54 Mn |
| Mar 31, 2023 | -150.15 Mn |
| Dec 31, 2022 | 42.33 Mn |
| Sep 30, 2022 | 45.15 Mn |
| Jun 30, 2022 | 32.54 Mn |
| Mar 31, 2022 | 6.93 Mn |
| Dec 31, 2021 | 16.61 Mn |
| Sep 30, 2021 | 19.54 Mn |
| Jun 30, 2021 | 7.97 Mn |
| Mar 31, 2021 | -2.91 Mn |
| Dec 31, 2020 | 13.13 Mn |
| Sep 30, 2020 | 2.05 Mn |
| Jun 30, 2020 | 13.30 Mn |
| Mar 31, 2020 | 12.24 Mn |
| Dec 31, 2019 | 44.53 Mn |
| Sep 30, 2019 | 21.57 Mn |
| Jun 30, 2019 | 4.34 Mn |
| Mar 31, 2019 | 2.52 Mn |
| Dec 31, 2018 | 5.94 Mn |
| Sep 30, 2018 | 728,374.00 |
| Jun 30, 2018 | -9.71 Mn |
| Mar 31, 2018 | -37.90 Mn |
| Dec 31, 2017 | 50.17 Mn |
| Sep 30, 2017 | -1.25 Mn |
| Jun 30, 2017 | -1.40 Mn |
| Mar 31, 2017 | -3.91 Mn |
| Dec 31, 2016 | -3.75 Mn |
| Sep 30, 2016 | -1.08 Mn |
| Jun 30, 2016 | -3.51 Mn |
| Mar 31, 2016 | -6.01 Mn |
| Dec 31, 2015 | -4.52 Mn |
| Sep 30, 2015 | -4.47 Mn |
| Jun 30, 2015 | -4.10 Mn |
| Mar 31, 2015 | 32.23 Mn |
| Dec 31, 2014 | -2.17 Mn |
| Sep 30, 2014 | -3.54 Mn |
| Jun 30, 2014 | 13.73 Mn |
| Mar 31, 2014 | -1.14 Mn |
| Dec 31, 2013 | -10.75 Mn |
| Sep 30, 2013 | 12.08 Mn |
| Jun 30, 2013 | 233,031.00 |
| Mar 31, 2013 | -763,894.00 |
| Dec 31, 2012 | -10.56 Mn |
| Sep 30, 2012 | 4.46 Mn |
| Jun 30, 2012 | 2.79 Mn |
| Mar 31, 2012 | -1.31 Mn |
| Dec 31, 2011 | 3.88 Mn |
| Sep 30, 2011 | -1.25 Mn |
| Jun 30, 2011 | -3.47 Mn |
| Mar 31, 2011 | 1.40 Mn |
| Dec 31, 2010 | -772,019.00 |
| Sep 30, 2010 | 638,809.00 |